AAPT Diagnostic Criteria for Fibromyalgia

Lesley M Arnold (Corresponding Author), Robert M Bennett, Leslie J Crofford, Linda E Dean, Daniel J Clauw, Don L Goldenberg, Mary-Ann Fitzcharles, Eduardo S Paiva, Roland Staud, Piercarlo Sarzi-Puttini, Dan Buskila, Gary J Macfarlane

Research output: Contribution to journalReview article

1 Citation (Scopus)
10 Downloads (Pure)

Abstract

Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

Original languageEnglish
Pages (from-to)611-628
Number of pages18
JournalJournal of Pain
Volume20
Issue number6
Early online date16 Nov 2018
DOIs
Publication statusPublished - Jun 2019

Fingerprint

Fibromyalgia
Pain
Somatoform Disorders
Clinical Trials
Chronic Pain
Research Personnel
Public-Private Sector Partnerships
United States Food and Drug Administration
Reproducibility of Results
Analgesics
Anesthetics
Comorbidity
Consensus

Keywords

  • Fibromyalgia
  • diagnosis
  • criteria
  • AAPT
  • dimensions
  • INTRINSIC BRAIN CONNECTIVITY
  • CHRONIC WIDESPREAD PAIN
  • OF-RHEUMATOLOGY 1990
  • MUSCULOSKELETAL PAIN
  • CENTRAL SENSITIZATION
  • HYPOTHALAMIC-PITUITARY
  • SYNDROME/EHLERS-DANLOS SYNDROME
  • HEALTH-CARE COSTS
  • CHRONIC-FATIGUE-SYNDROME
  • IRRITABLE-BOWEL-SYNDROME

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Anesthesiology and Pain Medicine

Cite this

Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., ... Macfarlane, G. J. (2019). AAPT Diagnostic Criteria for Fibromyalgia. Journal of Pain, 20(6), 611-628. https://doi.org/10.1016/j.jpain.2018.10.008

AAPT Diagnostic Criteria for Fibromyalgia. / Arnold, Lesley M (Corresponding Author); Bennett, Robert M; Crofford, Leslie J; Dean, Linda E; Clauw, Daniel J; Goldenberg, Don L; Fitzcharles, Mary-Ann; Paiva, Eduardo S; Staud, Roland; Sarzi-Puttini, Piercarlo; Buskila, Dan; Macfarlane, Gary J.

In: Journal of Pain, Vol. 20, No. 6, 06.2019, p. 611-628.

Research output: Contribution to journalReview article

Arnold, LM, Bennett, RM, Crofford, LJ, Dean, LE, Clauw, DJ, Goldenberg, DL, Fitzcharles, M-A, Paiva, ES, Staud, R, Sarzi-Puttini, P, Buskila, D & Macfarlane, GJ 2019, 'AAPT Diagnostic Criteria for Fibromyalgia' Journal of Pain, vol. 20, no. 6, pp. 611-628. https://doi.org/10.1016/j.jpain.2018.10.008
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL et al. AAPT Diagnostic Criteria for Fibromyalgia. Journal of Pain. 2019 Jun;20(6):611-628. https://doi.org/10.1016/j.jpain.2018.10.008
Arnold, Lesley M ; Bennett, Robert M ; Crofford, Leslie J ; Dean, Linda E ; Clauw, Daniel J ; Goldenberg, Don L ; Fitzcharles, Mary-Ann ; Paiva, Eduardo S ; Staud, Roland ; Sarzi-Puttini, Piercarlo ; Buskila, Dan ; Macfarlane, Gary J. / AAPT Diagnostic Criteria for Fibromyalgia. In: Journal of Pain. 2019 ; Vol. 20, No. 6. pp. 611-628.
@article{2ef4d19285e0459387ff44b2c0795d9c,
title = "AAPT Diagnostic Criteria for Fibromyalgia",
abstract = "Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.",
keywords = "Fibromyalgia, diagnosis, criteria, AAPT, dimensions, INTRINSIC BRAIN CONNECTIVITY, CHRONIC WIDESPREAD PAIN, OF-RHEUMATOLOGY 1990, MUSCULOSKELETAL PAIN, CENTRAL SENSITIZATION, HYPOTHALAMIC-PITUITARY, SYNDROME/EHLERS-DANLOS SYNDROME, HEALTH-CARE COSTS, CHRONIC-FATIGUE-SYNDROME, IRRITABLE-BOWEL-SYNDROME",
author = "Arnold, {Lesley M} and Bennett, {Robert M} and Crofford, {Leslie J} and Dean, {Linda E} and Clauw, {Daniel J} and Goldenberg, {Don L} and Mary-Ann Fitzcharles and Paiva, {Eduardo S} and Roland Staud and Piercarlo Sarzi-Puttini and Dan Buskila and Macfarlane, {Gary J}",
note = "Acknowledgements Support was provided by the Analgesic, Anesthetic, and Addictions Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with the US Food and Drug Administration (FDA).",
year = "2019",
month = "6",
doi = "10.1016/j.jpain.2018.10.008",
language = "English",
volume = "20",
pages = "611--628",
journal = "Journal of Pain",
issn = "1526-5900",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - AAPT Diagnostic Criteria for Fibromyalgia

AU - Arnold, Lesley M

AU - Bennett, Robert M

AU - Crofford, Leslie J

AU - Dean, Linda E

AU - Clauw, Daniel J

AU - Goldenberg, Don L

AU - Fitzcharles, Mary-Ann

AU - Paiva, Eduardo S

AU - Staud, Roland

AU - Sarzi-Puttini, Piercarlo

AU - Buskila, Dan

AU - Macfarlane, Gary J

N1 - Acknowledgements Support was provided by the Analgesic, Anesthetic, and Addictions Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with the US Food and Drug Administration (FDA).

PY - 2019/6

Y1 - 2019/6

N2 - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

AB - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

KW - Fibromyalgia

KW - diagnosis

KW - criteria

KW - AAPT

KW - dimensions

KW - INTRINSIC BRAIN CONNECTIVITY

KW - CHRONIC WIDESPREAD PAIN

KW - OF-RHEUMATOLOGY 1990

KW - MUSCULOSKELETAL PAIN

KW - CENTRAL SENSITIZATION

KW - HYPOTHALAMIC-PITUITARY

KW - SYNDROME/EHLERS-DANLOS SYNDROME

KW - HEALTH-CARE COSTS

KW - CHRONIC-FATIGUE-SYNDROME

KW - IRRITABLE-BOWEL-SYNDROME

UR - http://www.scopus.com/inward/record.url?scp=85058705131&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/aapt-diagnostic-criteria-fibromyalgia

U2 - 10.1016/j.jpain.2018.10.008

DO - 10.1016/j.jpain.2018.10.008

M3 - Review article

VL - 20

SP - 611

EP - 628

JO - Journal of Pain

JF - Journal of Pain

SN - 1526-5900

IS - 6

ER -